M. Malkin

NABTC phase I/II trial of ZD-1839 for recurrent malignant gliomas and unresectable meningiomas.

M. Prados, F. Lieberman, P. Wen, 2004, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.